| Literature DB >> 29674126 |
Marta Barba1, Lorena Di Pietro2, Luca Massimi3, Maria Concetta Geloso1, Paolo Frassanito4, Massimo Caldarelli3, Fabrizio Michetti2, Stefano Della Longa5, Paul A Romitti6, Concezio Di Rocco7, Alessandro Arcovito8, Ornella Parolini9, Gianpiero Tamburrini3, Camilla Bernardini1, Simeon A Boyadjiev10, Wanda Lattanzi11.
Abstract
Nonsyndromic craniosynostosis (NCS) is the premature ossification of skull sutures, without associated clinical features. Mutations in several genes account for a small number of NCS patients; thus, the molecular etiopathogenesis of NCS remains largely unclear. Our study aimed at characterizing the molecular signaling implicated in the aberrant ossification of sutures in NCS patients. Comparative gene expression profiling of NCS patient sutures identified a fused suture-specific signature, including 17 genes involved in primary cilium signaling and assembly. Cells from fused sutures displayed a reduced potential to form primary cilia compared to cells from control patent sutures of the same patient. We identified specific upregulated splice variants of the Bardet Biedl syndrome-associated gene 9 (BBS9), which encodes a structural component of the ciliary BBSome complex. BBS9 expression increased during in vitro osteogenic differentiation of suture-derived mesenchymal cells of NCS patients. Also, Bbs9 expression increased during in vivo ossification of rat sutures. BBS9 functional knockdown affected the expression of primary cilia on patient suture cells and their osteogenic potential. Computational modeling of the upregulated protein isoforms (observed in patients) predicted that their binding affinity within the BBSome may be affected, providing a possible explanation for the aberrant suture ossification in NCS.Entities:
Keywords: BBS9; Gene expression signatures; Innovative biotechnologies; Mesenchymal stromal cells; Nonsyndromic craniosynostosis; Primary cilium
Mesh:
Substances:
Year: 2018 PMID: 29674126 PMCID: PMC5970090 DOI: 10.1016/j.bone.2018.04.013
Source DB: PubMed Journal: Bone ISSN: 1873-2763 Impact factor: 4.398